HTR1B and myeloproliferative neoplasm: When comparing the level of HTR1B expression between MPN patients with/without thrombosis, non‐MPN thrombotic patients and control group a statistically significant difference was noted (p < 0.0001, Kruskal–Wallis test) (Figure 2C).